Advertisement
JBC

HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Originally published In Press as doi:10.1074/jbc.M101566200 on July 9, 2001

J. Biol. Chem., Vol. 276, Issue 36, 33393-33401, September 7, 2001
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
276/36/33393    most recent
M101566200v1
Right arrow Submit a Letter to Editor
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Raftery, M. J.
Right arrow Articles by Geczy, C. L.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Raftery, M. J.
Right arrow Articles by Geczy, C. L.
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

Novel Intra- and Inter-molecular Sulfinamide Bonds in S100A8 Produced by Hypochlorite Oxidation*

Mark J. RafteryDagger , Zheng Yang, Stella M. Valenzuela, and Carolyn L. Geczy

From the Cytokine Research Unit, School of Pathology, University of New South Wales, Kensington, New South Wales 2052, Australia

Hypochlorite is a major oxidant generated when neutrophils and macrophages are activated at inflammatory sites, such as in atherosclerotic lesions. Murine S100A8 (A8) is a major cytoplasmic protein in neutrophils and is secreted by macrophages in response to inflammatory stimuli. After incubation with reagent HOCl for 10 min, ~85% of A8 was converted to 4 oxidation products, with electrospay ionization mass spectrometry masses of m/z 10354, 10388, 10354 ± 1, and 20707 ± 3. All were resistant to reduction by dithiothreitol. Initial formation of a reactive Cys sulfenic acid intermediate was demonstrated by the rapid conjugation of 5,5-dimethyl-1,3-cyclohexanedione (dimedone) to HOCl-treated A8 to form stable adducts. Matrix-assisted laser desorption-reflectron time of flight peptide mass fingerprinting of isolated oxidation products confirmed the mass additions observed in the full-length proteins. Both Met36/73 were converted to Met36/73 sulfoxides. An additional product with an unusual mass addition of m/z 14 (±0.2) was identified and corresponded to the addition of oxygen to Cys41, conjugation to various epsilon -amines of Lys6, Lys34/35, or Lys87 with loss of dihydrogen and formation of stable intra- or inter-molecular sulfinamide cross-links. Specific fragmentations identified in matrix-assisted laser desorption-post source decay spectra and low energy collisional-induced dissociation tandem mass spectroscopy spectra of sulfinamide-containing digest peptides confirmed Lys34/35 to Cys41 sulfinamide bonds. HOCl oxidation of mutants lacking Cys41 (Ala41S100A8) or specific Lys residues (e.g. Lys34/35, Ala34/35S100A8) did not form sulfinamide cross-links. HOCl generated by myeloperoxidase and H2O2 and by phorbol 12-myristate 13-acetate-activated neutrophils also formed these products. In contrast to the disulfide-linked dimer, oxidized monomer retained normal chemotactic activity for neutrophils. Sulfinamide bond formation represents a novel oxidative cross-linking process between thiols and amines and may be a general consequence of HOCl protein oxidation in inflammation not identified previously. Similar modifications in other proteins could potentially regulate normal and pathological processes during aging, atherogenesis, fibrosis, and neurogenerative diseases.


* This work was supported in part by grants from the National Health and Medical Research Council of Australia and Australian Research Council.The costs of publication of this article were defrayed in part by the payment of page charges. The article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.

Dagger To whom correspondence should be addressed. Tel.: 61-2-9385-1599; Fax: 61-2-9385-1389; E-mail: m.raftery@unsw.edu.au.


Copyright © 2001 by The American Society for Biochemistry and Molecular Biology, Inc.
Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
J. Immunol.Home page
J. Goyette, W. X. Yan, E. Yamen, Y. M. Chung, S. Y. Lim, K. Hsu, F. Rahimi, N. Di Girolamo, C. Song, W. Jessup, et al.
Pleiotropic Roles of S100A12 in Coronary Atherosclerotic Plaque Formation and Rupture
J. Immunol., July 1, 2009; 183(1): 593 - 603.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
S. Y. Lim, M. Raftery, H. Cai, K. Hsu, W. X. Yan, H.-L. Hseih, R. N. Watts, D. Richardson, S. Thomas, M. Perry, et al.
S-Nitrosylated S100A8: Novel Anti-Inflammatory Properties
J. Immunol., October 15, 2008; 181(8): 5627 - 5636.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
T. Nakamura, T. Yamamoto, M. Abe, H. Matsumura, Y. Hagihara, T. Goto, T. Yamaguchi, and T. Inoue
Oxidation of archaeal peroxiredoxin involves a hypervalent sulfur intermediate
PNAS, April 29, 2008; 105(17): 6238 - 6242.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
W. Nguitragool and C. Miller
Inaugural Article: CLC Cl-/H+ transporters constrained by covalent cross-linking
PNAS, December 26, 2007; 104(52): 20659 - 20665.
[Abstract] [Full Text] [PDF]


Home page
Mol. Cell. ProteomicsHome page
R. L. Charles, E. Schroder, G. May, P. Free, P. R. J. Gaffney, R. Wait, S. Begum, R. J. Heads, and P. Eaton
Protein Sulfenation as a Redox Sensor: Proteomics Studies Using a Novel Biotinylated Dimedone Analogue
Mol. Cell. Proteomics, September 1, 2007; 6(9): 1473 - 1484.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
M. M. McCormick, F. Rahimi, Y. V. Bobryshev, K. Gaus, H. Zreiqat, H. Cai, R. S. A. Lord, and C. L. Geczy
S100A8 and S100A9 in Human Arterial Wall: IMPLICATIONS FOR ATHEROGENESIS
J. Biol. Chem., December 16, 2005; 280(50): 41521 - 41529.
[Abstract] [Full Text] [PDF]


Home page
Physiol. Rev.Home page
R. Stocker and J. F. Keaney Jr.
Role of Oxidative Modifications in Atherosclerosis
Physiol Rev, October 1, 2004; 84(4): 1381 - 1478.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
C. Bergt, X. Fu, N. P. Huq, J. Kao, and J. W. Heinecke
Lysine Residues Direct the Chlorination of Tyrosines in YXXK Motifs of Apolipoprotein A-I When Hypochlorous Acid Oxidizes High Density Lipoprotein
J. Biol. Chem., February 27, 2004; 279(9): 7856 - 7866.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
C. Ryckman, K. Vandal, P. Rouleau, M. Talbot, and P. A. Tessier
Proinflammatory Activities of S100: Proteins S100A8, S100A9, and S100A8/A9 Induce Neutrophil Chemotaxis and Adhesion
J. Immunol., March 15, 2003; 170(6): 3233 - 3242.
[Abstract] [Full Text] [PDF]


Home page
Mol. Cell. Biol.Home page
M.-P. Manitz, B. Horst, S. Seeliger, A. Strey, B. V. Skryabin, M. Gunzer, W. Frings, F. Schonlau, J. Roth, C. Sorg, et al.
Loss of S100A9 (MRP14) Results in Reduced Interleukin-8-Induced CD11b Surface Expression, a Polarized Microfilament System, and Diminished Responsiveness to Chemoattractants In Vitro
Mol. Cell. Biol., February 1, 2003; 23(3): 1034 - 1043.
[Abstract] [Full Text]


Home page
J. Biol. Chem.Home page
R. A. Kumar, A. Koc, R. L. Cerny, and V. N. Gladyshev
Reaction Mechanism, Evolutionary Analysis, and Role of Zinc in Drosophila Methionine-R-sulfoxide Reductase
J. Biol. Chem., September 27, 2002; 277(40): 37527 - 37535.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
J. E. Pimanda, D. S. Annis, M. Raftery, D. F. Mosher, C. N. Chesterman, and P. J. Hogg
The von Willebrand factor-reducing activity of thrombospondin-1 is located in the calcium-binding/C-terminal sequence and requires a free thiol at position 974
Blood, September 26, 2002; 100(8): 2832 - 2838.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 All ASBMB Journals   Molecular and Cellular Proteomics 
 Journal of Lipid Research   ASBMB Today 
Copyright © 2001 by the American Society for Biochemistry and Molecular Biology.
Advertisement
spacer
Advertisement
Advertisement